SEARCH

SEARCH BY CITATION

References

  • 1
    Tomasi TB Jr. Oral tolerance. Transplantation 1980;29:353356.
  • 2
    Curtis HH. The immunizing cure of hay fever. Med News New York 1900;77:1619.
  • 3
    Finkelstein H. Kuhmilch als Ursache von Ernährungsstörungen bei Säuglingen. Monatsschr Kinderheilk 1905;4:6572.
  • 4
    Feinberg SM, Foran EL, Lichtenstein MR, et al. Oral therapy in ragweed pollinosis, a comparative study. J Am Med Assoc 1940;115:2329.
  • 5
    Laetsch C, Wüthrich B. Zur peroralen Desensibilisierung von Inhalationsallergien im Kindesalter. Schweiz Med Wschr 1973;103:342350.
  • 6
    Stemmann EA, Wegner F, Schachoff R, Reinhardt D. Orale Hyposensibilisierung bei Kindern. Prax Pneumol 1979;33:302304.
  • 7
    Ebner H. Orale Hyposensibilisierung. Wien Klin Wschr 1980;92:1921.
  • 8
    Fischöder W, Neumann M, Veltmann G. Ergebnisse der subkutanen und oralen spezifischen Hyposensibilisierung mit Inhalationsallergenen. Allergologie 1982;5:2433.
  • 9
    Clasen I, Wüthrich B. Neuere Ergebnisse der peroralen Hyposensibilisierung beim kindlichen Asthma bronchiale. Mschr Kinderheilk 1976;124:248.
  • 10
    Wüthrich B. Pollinosis des Kindes als Prototyp einer atopischen Krankheit. Mschr Kinderheilk 1976;124:702705.
  • 11
    Wortmann F. Orale Hyposensibilisierung. Allergologie 1981;4:219224.
  • 12
    Jorde W, Linskens HF. Zur Persorption von Pollen und Sporen durch die intakte Darmschleimhaut. Acta Allergol 1974;29:165175.
  • 13
    Cohn JR, Pizzi A. Determinants of patient compliance with allergen immunotherapy. J Allergy Clin Immunol 1993;91:734737.
  • 14
    Malling H-J, Weeke B. EAACI Immunotherapy Position Paper. Allergy 1993;38:945.
  • 15
    Hejjaoui J, Ferrando R, Dhivert H, Michel FB, Bousquet J. Systemic reactions occurring in immunotherapy with standardized pollen extracts. J Allergy Clin Immunol 1992;89:925933.
  • 16
    Tabar AL, Garcia BE, Rodriquez A, Olaguibel JM, Muro MD, Quirce S. A prospective safety monitoring study of immunotherapy with biologically standardized extracts. Allergy 1993;48:450453.
  • 17
    Holt PG, Batty JE, Tumer KJ. Inhibition of specific IgE responses in mice by pre-exposure to inhaled antigen. Immunology 1981;42:409417.
  • 18
    Holt PG, Sedgewick JD. Suppression of IgE responses following inhalation of antigen. A natural homeostatic mechanism which limits sensitization to aeroallergens. Immunol Today 1987;8:1426.
  • 19
    Holt PG, Britten D, Sedgewick JD. Suppression of IgE responses by antigen inhalation: studies on the role of genetic and environmental factors. Immunology 1987;60:97102.
  • 20
    Hok PG, McMenamin C. Defence against allergic sensitization in healthy lung: the role of inhalation tolerance. Clin Exp Allergy 1989;19:5562.
  • 21
    Mowart AM. The regulation of immune response to dietary proteins. Immunol Today 1987;8:9396.
  • 22
    Holt PG, Vines J, Britten D. Sublingual allergen administration. 1. Selective suppression of IgE production in rats by high allergen doses. Clin Allergy 1988;18:229234.
  • 23
    Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:12371240.
  • 24
    Eriksson K, Ahlfors E, George-Chandy A, Kaiserlian D, Czerkinsky C. Antigen presentation in the murine oral epithelium. Immunology 1996;88:147152.
  • 25
    Noirey N, Rougier N, André C, Schmitt D, Vincent C. Langerhans-like dendritic cells generated from cord blood progenitors internalise pollen allergens by macropinocytosis, and part of the molecules are processed and can activate autologous naïve T-lymphocytes. Clin Allergy 2000;13:509513.
  • 26
    Van-Wilsem EI, Van-Hoogstraten IM, Breve J, Scheper RJ, Kraal G. Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair. Immnology 1994;83:128132.
  • 27
    Hasseus B, Dahlgren U, Bergenholtz G, Jontell M. Antigen presenting capacity of Langerhans cells from rat oral epithelium. J Oral Pathol Med 1995;24:5660.
  • 28
    Manetti R, Parronchi P, Giudizi MG, et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1) -specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:11991204.
  • 29
    Macatonia SE, Hosken NS, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4 + T cells. J Immunol 1995;154:50715079.
  • 30
    Volkheimer G. Persorption. In: Bartelheimer, H, Kühn, HA, Becker, V, Stelzner, F, editors. Gastroenterologie und Stoffwechsel Bd. 2. Stuttgart: Thieme, 1972.
  • 31
    Hemmings WA, Williams EW. Transport of large breakdown products of dietary protein through the gut wall. Gut 1978;19:715723.
  • 32
    Wells HG, Osborne TB. The biological reactions to the vegetable proteins. I. Anaphylaxis. J Infect Dis 1911;8:6674.
  • 33
    Alexander HL, Shirley K, Allen D. The route of ingested egg white to the systemic circulation. J Clin Invest 1936;15:163169.
  • 34
    Hemmings WA. Antigen Absorption by the Gut. Lancaster: MTP Press. 1978.
  • 35
    Lens JW, Van Den Berg WB, Van De Putte LBA, Van Den Berselaar L. Flare-up of antigen-induced arthritis in mice after challenge with oral antigen. Clin Exp Immunol 1984;58:364371.
  • 36
    Seifert J. Enterale Resorption grossmolekularer Proteine bei Tieren und Menschen. Z Ernährungswissenschaft Supplement 1976;18:(Suppl.).
  • 37
    Warshaw AL, Bellini CA, Walker WA. The intestinal mucosal barrier to intact antigenic protein. Difference between colon and small intestine. Am J Surg 1977;133:5558.
  • 38
    Udall JN, Walker WA. Antigentransport im Darm. Allergologie 1984;7:263269.
  • 39
    Jackson PG, Baker RWR, Lessof MH, Ferret J, MacDonald MD. Intestinal permeability in patients with eczema and food allergy. Lancet 1981;I:12851286.
  • 40
    Atherton DJ, Heddle RJ, Boulton P. Intestinal permeability in atopic eczema. Brit J Dermat 1984;111: (Suppl.):34–35.
  • 41
    Fälth-Magnusson K, Kjellmann N-IM, Magnusson KE, Sundkvist T. Intestinal permeability in healthy and allergic children before and after sodium-cromoglycate treatment assessed with different sized polyethylenglycols (PEG 400 PEG 1000). Clin Allergy 1984;14:277286.
  • 42
    Ukabam SO, Mann RJ, Cooper BT. Small intestinal permeability to sugars in patients with atopic eczema. Br J Dermatol 1984;110:649652.
  • 43
    Bjarnason I, So A, Levi AJ, et al. Intestinal permeability and inflammation in rheumatoid arthritis: Effects of non-steroidal anti-inflammatory drugs. Lancet 1984;II:11711173.
  • 44
    Tomasi TB Jr, Larson L, Challacombe S, McNabb P. Mucosal immunity: The origin and migration patterns of cells in the secretory immune system. J Allergy Clin Immunol 1980;65:1219.
  • 45
    Bienenstock J. The mucosal immunologic network. Ann Allergy 1984;53:535540.
  • 46
    Börsch G. Der Gastrointestinaltrakt als Immunorgan: Das darmassoziierte Immunsystem. Klin Wschr 1984;62:699701.
  • 47
    Pabst R. Der Verdauungstrakt als Immunorgan. Med Klin Praxis, 1983;78:1420.
  • 48
    Mestecky JJ, McGhee JR, Arnold RR, Michalek SM, Price SJ, Blabb JL. Selective induction of an immune response in human external secretions by ingestion of bacterial antigen. J Clin Invest, 1978;61:731737.
  • 49
    Lafont S, André C, André F, Gillon J, Fargier M-C. Abrogation by subsequent feeding of antibody response, inlcuding IgE, in parenterally immunized mice. J Exp Med, 1982;155:15731578.
  • 50
    Cebra JJ, Fuhrmann JA, Griffin P, Rose FV, Schweitzer PA, Zimmerman D. Changes in specific B-cells and the dissemination of the primed state in vivo following antigenic stimulation by different mucosal routes. Ann Allergy, 1984;53:541549.
  • 51
    MacDonald TTB. Enhancement and suppression of the Peyer's patch immune response by systemic priming. Clin Exp Immunol 1982;49:441448.
  • 52
    Nickelsen JA, Georgitis JW, Mueller UR, et al. Local nasal immunotherapy for ragweed-allergic-rhinitis. Clin Allergy 1983, Year?;13:509513.
  • 53
    Sulzberger MB. Hypersensitiveness to neoarsphenamine in guinea-pigs: Experiments in prevention and in desensitization. Arch Derm Syph 1929;20:669681.
  • 54
    Chase WM. Inhibition of experimental drug allergy by prior feeding of the sensitizing antigen. Proc Soc Exp Biol Medical 1946;61:257264.
  • 55
    Bloch KJ, Perry RB, Bloch M, Walker WA. Feeding of antigen reduces antigen-binding activity and blunts the secondary response of actively immunized rats. J Allergy Clin Immunol 1984;74:482488.
  • 56
    Wahn U, Maasch HJ, Geissler W. Leukocyte histamine release and humoral changes during oral and subcutaneous hyposensitization of grass pollen allergic children. Helv Paediatr Acta 1984;39:137144.
  • 57
    Mayron LW. Wells and Osborne revisited: Immune tolerance. Ann Allergy 1979;42:177182.
  • 58
    Saklayen MG, Pesce AJ, Pollak VE, Michael JG. Kinetics of oral tolerance: Study of variables affecting tolerance induced by oral administration of antigen. Int Arch Allergy Appl Immun 1984;73:59.
  • 59
    Brueton M. Tolerance, hypersensitivity and the gut in childhood. Clin Allergy 1983;13:583.
  • 60
    Challacombe SJ, Tomasi TB Jr. Systemic tolerance and secretory immunity after oral immunziation. J Exp Med 1980;152:14591472.
  • 61
    Jarrett E, Hall E. Regulation of ongoing IgE antibody responses with minute doses of antigen. Europ J Immunol, 1981;11:520523.
  • 62
    Strober W, Richman LK, Elson CO. The regulation of gastrointestinal immune response. Immunol Today 1981;2:156162.
  • 63
    Swarbrick ET, Stokes CR, Soothill JF. Genetic differences in the handling of ingested antigens by the gut. Clin Allergy 1981;11:192193.
  • 64
    Freier S, Kuperman O. Immune regulation in the gastrointestinal tract. J Paediatr Gastroenterol 1983;2:310314.
  • 65
    Kleinman RE. The role of developmental immune mechanisms in intestinal allergy. Ann Allergy 1984;51:222225.
  • 66
    Durham SR, Varney V, Gaga M, Frew AJ, Jacobson M, Kay AB. Immunotherapy and allergic inflammation. Clin Exp Allergy 1991;21:206210.
  • 67
    Kuitunen M, Savilahti E. Mucosal IgA, mucosal cow's milk antibodies, serum cow's milk antibodies and gastrointestinal permeability in infants. Pediatr Allergy Immunol 1995;6:3035.
  • 68
    Dreborg S, Frew A. Allergen standardization and skin test. Allergy 1993;48:4982.
  • 69
    Giovane AL, Bardare M, Passalaqua G, Ruffoni S, Scordamaglia A, Ghezzi E, Canonica GW. A three-year double blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. Clin Exp Allergy 1994;24:5359.
  • 70
    Johansson SGO, Deutschl H, Zetterström O. Use of glutaraldehyde-modified timothy grass pollen extract in nasal hyposensitisation treatment of hay fever. In. Archs Allergy appl Immunol 1979;60:447460.
  • 71
    Nickelsen JA, Goldstein S, Mueller U, Wypych J, Reisman RE, Arbesman CE. Local intranasal immunotherapy for ragweed allergic rhinitis. 1. Clinical response. J Allergy Clin Immunol 1981;68:3340.
  • 72
    Welsh PW, Zimmermann EM, Yunginger JW, Kern EB, Gleich GJ. Preseasonal intranasal immunotherapy with nebulized short ragweed extract. J Allergy Clin Immunol 1981;67:237242.
  • 73
    Schumacher MJ, Pain MC. Intranasal immunotherapy and polymerized grass pollen allergens. Allergy 1982;37:241248.
  • 74
    Georgitis JW, Reisman RE, Clayton WF, Mueller UR, Wypych JI, Arbesman CE. Local intranasal immunotherapy for grass-allergic rhinitis. J Allergy Clin Immunol 1983;71:7176.
  • 75
    Georgitis JW, Clayton WF, Wypych IJ, Barde SH, Reisman RE. Further evaluation of local intranasal immunotherapy with aqueous and allergoid grass extracts. J Allergy Clin Immunol 1984;74:694700.
  • 76
    Andri L, Senna GE, Betteli C, et al. Local nasal immunotherapy in allergic rhinitis to Parietaria. A double-blind controlled study. Allergy 1992;47:318323.
  • 77
    Andri L, Senna GE, Betteli C, Givainni S, Andri G, Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol 1993;91:987996.
  • 78
    Passalacqua G, Albano M, Ruffoni S, et al. Nasal immunotherapy to Parietaria: evidence of reduction of local inflammation. Am J Respir Crit Care Med 1995;152:461466.
  • 79
    D'Amato G, Lobefalo G, Liccardi G, Cazzola M. A double-blind, placebo-controlled trial of local nasal immunotherapy in allergic rhinitis to Parietaria pollen. Clin Exp Allergy 1995;25:141148.
  • 80
    Andri L, Senna G, Andri G, et al. Local nasal immunotherapy for birch allergic rhinitis with extract in powder form. Clin Exp Allergy 1995;25:10921099.
  • 81
    Andri L, Senny G, Betteli C, et al. Local nasal immunotherapy with extract in powder form is effective and safe in grass-pollen rhinitis. A double blind study. J Allergy Clin Immunol 1996;97:3441.
  • 82
    Cirla AM, Sforza N, Roffi GP, et al. Preseasonal intranasal immunotherapy in birch-alder allergic rhinitis. A double-blind study. Allergy 1996;51:299305.
  • 83
    Bardare M, Zani G, November E, Vierucci A. Local nasal immunotherapy with a powder extract for grass pollen induced rhinitis in pediatric ages: a controlled study. J Invest Allergo Immunol 1996;6:359363.
  • 84
    Galgani B, Borish L, Bartelson BL, Buchmeier A, Keller L, Nelson HS. Nasal immunotherapy in weed-induced allergic rhinitis. Ann Allergy Asthma Immunol 1997;79:259265.
  • 85
    Passalacqua G, Albano M, Pronzato C, et al. Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. A double-blind study. Clin Exp Allergy 1997;27:904908.
  • 86
    Bertoni M, Cosmi F, Bianchi I, Di Berardino L. Clinical efficacy and tolerability of a steady dosage schedule of local nasal immunotherapy. Results of preseasonal treatment in grass pollen rhinitis. Ann Allergy Asthma Immunol 1999;82:4751.
  • 87
    Motta G, Tassali D, De Vincentiis I, et al. A multicenter trial of specific local nasal immunotherapy. Laryngoscope 2000;110:132139.
  • 88
    Crimi E, Voltolini S, Troise C, et al. Local immunotherapy with Dermatophagoides extract in asthma. J Allergy Clin Immunol 1991;87:721728.
  • 89
    Tari MG, Mancino M, Monti G. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma: a double-blind study. J Invest Allergol Clin Immunol 1992;2:5967.
  • 90
    Cooper PJ, Darbyshire J, Nunn AJ, Warner JO. A controlled trial of oral hyposensitization in pollen asthma and rhinitis in children. Clin Allergy 1984;40:321335.
  • 91
    Taudorf E, Laursen LC, Djurup R, et al. Oral administraion of grass pollen to hay fever patients. An efficacy study in oral hyposensitization. Allergy 1985;40:321335.
  • 92
    Möller C, Dreborg S, Lanner A, Björksten B. Oral immunotherapy of children with rhinoconjunctivitis due to birch pollen allergy. A double blind study. Allergy 1986;41:271279.
  • 93
    Mosbech H, Dreborg S, Madsen F, et al. High dose grass pollen tablets used for hyposensitization in hay fever patients. A one-year double blind placebo controlled study. Allergy 1987;42:451455.
  • 94
    Taudorf E, Laursen LC, Lanner A, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol 1987;80:153161.
  • 95
    Oppenheimer J, Areson JG, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol 1994;93:6167.
  • 96
    Litwin A, Flanagan M, Entis G, et al. Oral immunotherapy with short ragweed extract in a novel encapsulated preparation. J Allergy Clin Immunol 1997;100:3038.
  • 97
    Van Deusen MA, Angelini BL, Cordoro KM, Seiler BA, Wood L, Skoner DP. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol 1997;78:573580.
  • 98
    Bousquet J, Lockey RF, Malling HJ. WHO Position Paper Allergen immunotherapy. Therapeutic vaccines for allergic diseases. Allergy 1998;53:.
  • 99
    Einarsson R, Reneck B, Taudorf E. In vitro studies of degradation of birch and timothy pollen allergen preparations by human duodenal juice. Allergy 1988;43:469472.
  • 100
    Nelson HS, Oppenheimer J, Vatsia GA, Buchmeier A. A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract. J Allergy Clin Immunol 1993;92:229236.
  • 101
    Feliziani V, Lattuada G, Parniani S, Dall'Aglio PP. Safety and efficacy of sublingual rush immunotherapy with grass allergen extracts. A double blind study. Allergol Immunopathol 1995;23:224230.
  • 102
    Pajno GB, Morabito L, Barberio G, Parmiani S. Clinical and immunologic effects of long-term sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, placebo-controlled study. Allergy 2000;55:842849.
  • 103
    Tari MG, Mancino M, Monti G. Efficacy of sublingual immunotherapy in patients with rhinitis and asthma due to house dust mite. A double blind study. Allergol Immunopathol 1990;18:277284.
  • 104
    Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 1998;351:629632.
  • 105
    Bousquet J, Scheinmann P, Guinnepain MT, et al. Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 1999;54:249260.
  • 106
    Guez S, Vatrinet C, Fadel R, André C. House-dust-mite sublingual-swallow immunotherapy (SLIT) in perennial rhinitis: a double-blind, placebo-controlled study. Allergy 2000;55:369375.
  • 107
    Sabbah A, Hassoun S, Le Sellin J, Andre C, Sicard H. A double blind placebo controlled trial by the sublingual route of immunotherapy with a standardized grass pollen extract. Allergy 1994;49:309313.
  • 108
    Clavel R, Bousquet J, André C. Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 1998;53:493498.
  • 109
    Pradalier A, Basset D, Claudel A, et al. Sublingual-swallow immunotherapy (SLIT) with a standardized five-grass-pollen extract (drops an sublingual tablets) versus placebo in seasonal rhinitis. A double-blind, randomized, placebo controlled study with 126 patients. Allergy 1999;54:819828.
  • 110
    Troise C, Votolini S, Canessa A, Pecora S, Negrini AC. Sublingual immunotherapy in parietaria pollen induced rhinitis: a double blind study. J Invest Allergol Clin Immunol 1995;5:2530.
  • 111
    Larosa M, Ranno C, André C, Carat F, Tosca MA, Canonica GW. Double-blind placebo-controlled evaluation of sublingual-swallow immunotherapy with standardized Parietaria judaica extract in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 1999;104:425432.
  • 112
    Horak F, Stübner P, Berger UE, Marks B, Toth J, Jäger S. Immunotherapy with sublingual birch pollen extract. A short-term double blind placebo study. J Invest Allergol Clin Immunol 1998;8:165171.
  • 113
    Vourdas D, Syrigou E, Potamianou P, et al. Double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized olive pollen extract in pediatric patients with allergic rhinoconjunctivitis and mild asthma due to olive pollen sensitization. A double-blind, randomized, placebo-controlled study with 66 children. Allergy 1998;53:662672.
  • 114
    André C, Vatrinet C, Galvain S, Carat F, Sicard H. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol 2000;121:229234.
  • 115
    Aria Working Group. Management of allergic rhinitis and its impact on asthma. A pocket guide for physicians and nurses, in press.
  • 116
    Rebien W, Purtonen E, Maash HJ, Stix E, Wahn U. Clinical and immunological response to oral and subcutaneous immunotherapy with grass pollen extracts. A prospective study. Eur J Pediatr 1982;138:341344.
  • 117
    Palacios AS, Medina FS, Rua-Figueroa AL, Millares CB, Santos SR, Marrero JAG. Comparative clinical-immunological study of oral and subcutaneous immunotherapy in children with extrinsic bronchial asthma. Allergol Immunopathol 1989;17:323329.
  • 118
    Urbanek R, Bürgelin KH, Kahle W, Wahn U. Oral immunotherapy with grass pollen in enterosoluble capsules. Eur J Pediatr 1990;149:545555.
  • 119
    Moscato G, Rossi G, Dellabiance A, Pisati A, Vinci G, Biale C. Local immunotherapy by inhalation of a powder extract in asthma due to house dust mite Dermatophagoides pteronyssinus: a double-blind comparison with parenteral immunotherapy. J Invest Allergol Clin Immunol 1991;1:383394.
  • 120
    Corbetta L, Pesiri P, Ferro G, Mander A. Improvement of fog and exercise induced asthma after local and subcutaneous immunotherapy in mite asthma. Allergol Immunopathol 1992;20:6066.
  • 121
    Piazza I. Bizzaor. Humoral response to subcutaneous, oral and nasal immunotherapy for allergic rhinitis due to Dermatophagoides pteronyssinus. Ann Allergy 1993;711:461469.
  • 122
    Bernadis P, Agnoletto M, Puccinelli P, Parmiani S, Pozzan M. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. J Invest Allergol Clin Immunol 1996;6:5562.
  • 123
    Quirino T, Iemoli E, Siciliani E, Parmiani S, Milazzo F. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Clin Exper Allergy 1996;26:12531261.
  • 124
    Khinchi MS, Poulsen LK, Carat F, André C, Malling HJ. Clinical efficacy of sublingual-swallow and subcutaneous immunotherapy in patients with allergic rhinoconjunctivitis due to birch pollen. A placebo-controlled, double-blind, double-dummy study. In: Allergologia Immunologia Pediatrica. Meeting Internazionale della Società Italiana di Allergologia ed Immunologia Pediatrica Firenze 29-30-31 Marzo 2001. Milano: Editrice C.S.H. 2001::143147.
  • 125
    Johansson SGO, O'B Hourihane J, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, Van Cauwenberge P, Van Hage-Hamsten M, Wüthrich B. A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813824.